首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1271240

微针流感疫苗市场，按产品类型、疫苗类型、流感类型（A型、B型流感）、地区 - 规模、份额、前景、机会分析2023-2030

Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Flu Type (Influenza A, Influenza B), By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年03月28日 | 出版商:

Coherent Market Insights | 英文 193 Pages | 商品交期: 2-3个工作天内

价格

简介目录

使用透皮贴剂通过皮肤输送药物始终能有效对抗病毒感染和流感。经皮药物递送主要通过被动药物扩散有效地进行，然后已经进行了通过各种作用机制（例如离子电渗疗法和超声导入）的经皮递送系统的药物开发。此外，製药公司已专注于开发微针疫苗，因为它们对于非常大的离子和亲水性药物分子的透皮递送非常有用。在微针中，有一种药物以穿透皮肤的针状进入体内。微针有多种尺寸、形状和功能，所有这些都用于替代其他输送方法，例如传统的皮下注射针头和其他注射装置。

微针贴片旨在将药物精确输送到富含免疫细胞的皮内空间，提供一种非侵入性和自我应用的疫苗接种方法，为疫苗接种提供了一种可行的替代方案。无需皮下注射针头和训练有素的医疗人员人员。

市场动态

为了扩大产品组合，市场上的主要参与者越来越多地采用产品发布等有机增长策略，预计这将在预测期内推动市场增长。例如，2021 年 6 月，主要美容和医疗製造商 Eclipse Foundation 宣布推出新产品 MicroPen EVO，这是一种医疗微针设备。

市场参与者增加微针流感疫苗的临床试验以扩大其产品组合，预计将在预测期内推动市场增长。例如，2021 年 7 月，处于临床阶段的生物製药公司 Micron Biomedical, Inc. 宣布已开始一项基于微针的麻疹风疹疫苗的儿科临床试验。

这项研究的主要特点

本报告对全球微针流感疫苗市场进行了深入分析，并展示了以 2022 年为基准年的预测期 (2023-2030) 的市场规模和復合年增长率。
它揭示了各个细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
它根据以下参数介绍了全球微针流感疫苗市场的主要参与者：公司亮点、产品组合、主要亮点、财务业绩和战略。
这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
《全球微针流感疫苗市场报告》面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以通过用于分析全球微针流感疫苗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写

第二章市场展望

报告概述
- 市场定义和范围
执行摘要
- 按产品类型划分的市场概况
- 市场概况，按疫苗类型
- 市场概况，按流感类型
- 市场概况：按地区
连贯机会图 (COM)

第3章市场动态、规律及趋势分析

市场动态
- 司机
- 约束因素
- 市场吸引力分析
- 市场机会
产品公告
合併、收购、联合研究
监管准则和合规性
主要发展状况
害虫分析
疫苗类型情况
对 PORTER 的分析
价格分析 (2021)

第 4 章全球微针流感疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响

经济影响
COVID-19 的流行病学特征
对供需的影响

第 5 章按产品类型划分的全球微针流感疫苗市场，2017-2030

实心微针
空心微针
涂层微针
可溶性微针

第 6 章全球微针流感疫苗市场，按疫苗类型分列，2017-2030

三价流感疫苗
四价流感疫苗

第 7 章全球微针流感疫苗市场，按流感类型分列，2017-2030

甲型流感
甲型H1N1
H3N2 型
乙型流感

第 8 章全球微针流感疫苗市场，按地区划分，2017-2030

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
欧洲
英国
德国
意大利
法国
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
东盟
澳大利亚
韩国
其他亚太地区
中东
海湾合作委员会
以色列
其他中东地区
非洲
北非
中非
南非

第9章竞争格局

疫苗公司：
- Vaccine Companies：
  - Sanofi
  - GC Pharma
- Microneedle Companies：
  - Harro Hofliger
  - CosMED Pharmaceutical Co.Ltd.
  - Micron Biomedical, Inc.
  - LTS Lohmann Therapie-Systeme AG
  - Micralyne, Inc.
  - Sorrento Therapeutics, Inc.
  - TSRL, Inc.
  - QUADMEDICINE
  - Raphas Co., Ltd.
  - Cutanos GmbH
  - 3M
  - NanoPass
  - Corium, Inc.
  - BD
  - FluGen, Inc.
  - MICRODERMICS INC
第 10 章
- 调查方法
- 关于出版商

简介目录

Product Code: CMI2286

Drug delivery through the skin using transdermal patches has always been effective against viral infections and influenza. Transdermal drug delivery is primarily efficient through passive drug diffusion followed by drug development of transdermal delivery systems through various mechanisms of action such as iontophoresis and sonophoresis. Moreover, pharmaceutical companies have focused on the development of microneedle vaccines because of their great utility for transdermal delivery of very large ionic and hydrophilic drug molecules. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus.

Microneedle patches are designed to precisely deliver drugs into the intradermal space, rich in immune cells, and provide a noninvasive and self-applicable vaccination approach, eliminating the need for hypodermic needles and trained medical personnel for vaccine administration.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launches by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2021, Eclipse Foundation, a leading aesthetic and medical manufacturer, announced the launch of its new product MicroPen EVO, which is a medical-grade micro-needling device.

The increasing clinical trials of the microneedle flu vaccine by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in July 2021, Micron Biomedical, Inc., a clinical stage biopharmaceutical company announced that it has begun trialing a microneedle-based measles-rubella vaccine in children.

Key features of the study:

This report provides in-depth analysis of the global microneedle flu vaccine market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global microneedle flu vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Sanofi, GC Pharma, Harro Hofliger, CosMED Pharmaceutical Co.Ltd., Micron Biomedical, Inc., LTS Lohmann Therapie-Systeme AG, Micralyne, Inc., Sorrento Therapeutics, Inc., TSRL, Inc., QUADMEDICINE, Raphas Co., Ltd., Cutanos GmbH, 3M, NanoPass, Corium, Inc., BD, FluGen, Inc., MICRODERMICS INC
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global microneedle flu vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microneedle flu vaccine market

Detailed Segmentation:

Global Microneedle Flu Vaccine Market, By Product Type:
- Solid Microneedles
- Hollow Microneedles
- Coated Microneedles
- Dissolving Microneedles
Global Microneedle Flu Vaccine Market, By Vaccine :
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
Global Microneedle Flu Vaccine Market By Flu Type:
- Influenza A
  - H1N1
  - H3N2
- Influenza B
Global Microneedle Flu Vaccine Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Sanofi*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GC Pharma
- Harro Hofliger
- CosMED Pharmaceutical Co.Ltd.
- Micron Biomedical, Inc.
- LTS Lohmann Therapie-Systeme AG
- Micralyne, Inc.
- Sorrento Therapeutics, Inc.
- TSRL, Inc.
- QUADMEDICINE
- Raphas Co., Ltd.
- Cutanos GmbH
- 3M
- NanoPass
- Corium, Inc.
- BD
- FluGen, Inc.
- MICRODERMICS INC

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Flu Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Vaccine Type Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Microneedle Flu Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Microneedle Flu Vaccine Market, By Product Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Solid Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hollow Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Coated Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Dissolving Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Microneedle Flu Vaccine Market, By Vaccine Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Trivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Quadrivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Microneedle Flu Vaccine Market, By Flu Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Influenza A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
H1N1
H3N2
Influenza B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Microneedle Flu Vaccine Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa